Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Dupuytrens Disease Therapeutics Market
Dupuytrens Disease Therapeutics Market Size
- Report ID: GMI10672
- Published Date: Aug 2024
- Report Format: PDF
Dupuytren’s Disease Market Size
Dupuytren’s disease therapeutics market size was valued at around USD 889.4 million in 2023 and is estimated to grow at 12.2% CAGR from 2024 to 2032. Dupuytren’s disease, also known as dupuytren's contracture, is a hand deformity that develops over years. It affects a layer of tissue that lies under the skin of the palm. Knots of tissue form under the skin, eventually creates a thick cord that can pull one or more fingers into a bent position.
The rising prevalence for dupuytren's disease is a significant driver for the market. For instance, according to the 2020 study published by the National Center for Biotechnology Information (NCBI), the global prevalence of dupuytren's disease was estimated to be about 8.2%. Thus, underscoring an urgent need for effective therapeutic solutions and the substantial market potential for treatments targeting this widespread condition. Furthermore, advancements in drug delivery technologies and rising geriatric population are also among the promoting factors advancing the growth of the market.
| Report Attribute | Details |
|---|---|
| Base Year: | 2023 |
| Dupuytrens Disease Therapeutics Market Size in 2023: | USD 889.4 Million |
| Forecast Period: | 2024 to 2032 |
| Forecast Period 2024 to 2032 CAGR: | 12.2% |
| 2032 Value Projection: | USD 2.5 Billion |
| Historical Data for: | 2021 - 2023 |
| No. of Pages: | 119 |
| Tables, Charts & Figures: | 214 |
| Segments covered: | Type, Therapeutics, Distribution Channel, and Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
Frequently Asked Questions (FAQ) :
Dupuytrens Disease Therapeutics Market Scope
